A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare

Biogen, Eli Lilly drugs to expand imaging market for companies in diagnostics sector.

Biogen to Cut Roughly 11% of Workforce to Focus on Big-Return Drugs

The biotech company cited the launch of Alzheimer’s drug Lekembi as part of its new focus…

Dove Maker Unilever Still Raising Prices as Volumes Slip

The consumer-goods giant — a scourge for the global economy and consumer sentiment — raised prices…

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies, even as many multinationals are turning their attention elsewhere.

WSJ News Exclusive | At Startup That Says Its AI Writes Medical Records, Humans Do a Lot of the Work

DeepScribe relies on a team of people to review technology-generated reports, listen in on medical conversations,…

How U.S. Drug Companies Could Tip Europe Into Recession

Fluctuations in Ireland’s pharmaceutical industry, often caused by tax moves by US-based companies, have a strong…

Dow Edges Higher, Its 10th Gain in a Row

Healthcare and financial stocks moved into positive territory this week for the year.

Tornado Damages Key Pfizer Drugmaking Plant

The plant in Rocky Mount, NC, produces a quarter of the sterile injectable drugs used by…

Johnson & Johnson Rips Off the Kenvue Band-Aid

The surprisingly quick delivery and extended evaluation hit J&J’s consumer health arm hard.

Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue

The pharmaceutical company’s net income rose 6.9% to $5.14 billion, or $1.96 per share.